Compare Prudential Financial Inc (PRU) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential Financial Inc vs 10X Genomics Inc — how do they compare? Prudential Financial Inc trades at $118.18 (market cap $40.97B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Prudential Financial Inc is far larger — about 7.5× 10X Genomics Inc's market cap, and Prudential Financial Inc pays a 4.75% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| PRU | TXG | |
|---|---|---|
Market Cap | $40.97B | $5.48B |
Sector | Financials | Health |
52-Week High | $119.07 | $47.20 |
52-Week Low | $92.00 | $11.34 |
Enterprise Value | $68.03B | $5.02B |
Dividend Yield | 4.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
